Hyperion DeFi (NASDAQ:HYPD) Director Ellen Strahlman Purchases 12,112 Shares

Hyperion DeFi, Inc. (NASDAQ:HYPD) Director Ellen Strahlman acquired 12,112 shares of the business’s stock in a transaction dated Monday, December 29th. The stock was purchased at an average price of $3.60 per share, with a total value of $43,603.20. Following the completion of the acquisition, the director directly owned 91,161 shares in the company, valued at approximately $328,179.60. This represents a 15.32% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Hyperion DeFi Price Performance

Shares of NASDAQ HYPD traded down $0.13 during trading hours on Tuesday, reaching $3.37. 193,370 shares of the stock traded hands, compared to its average volume of 1,525,525. The company’s 50-day simple moving average is $4.87 and its two-hundred day simple moving average is $7.60. The company has a market capitalization of $27.53 million, a P/E ratio of -0.83 and a beta of 2.81. Hyperion DeFi, Inc. has a 52-week low of $0.85 and a 52-week high of $17.99. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.11.

Hyperion DeFi (NASDAQ:HYPD) last issued its earnings results on Friday, November 14th. The company reported $0.05 earnings per share (EPS) for the quarter. The business had revenue of $0.36 million during the quarter. Hyperion DeFi had a negative return on equity of 119.59% and a negative net margin of 62,238.41%. Equities research analysts forecast that Hyperion DeFi, Inc. will post -41.6 EPS for the current year.

Analysts Set New Price Targets

Several research firms have weighed in on HYPD. Cantor Fitzgerald began coverage on shares of Hyperion DeFi in a research note on Tuesday, December 16th. They issued an “overweight” rating and a $4.00 price target for the company. Weiss Ratings restated a “sell (d-)” rating on shares of Hyperion DeFi in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Hyperion DeFi from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Finally, Chardan Capital set a $7.75 price target on shares of Hyperion DeFi and gave the stock a “buy” rating in a report on Wednesday, December 24th. Two equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Hyperion DeFi currently has a consensus rating of “Hold” and an average target price of $4.58.

About Hyperion DeFi

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.